USA - New York Stock Exchange - NYSE:ALUR - US02008G2012 - Common Stock
The current stock price of ALUR is 1.755 USD. In the past month the price increased by 15.46%. In the past year, price decreased by -40.1%.
ChartMill assigns a technical rating of 3 / 10 to ALUR. When comparing the yearly performance of all stocks, ALUR is a bad performer in the overall market: 88.35% of all stocks are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | N/A | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
8 analysts have analysed ALUR and the average price target is 5.36 USD. This implies a price increase of 205.13% is expected in the next year compared to the current price of 1.755.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| SCI | SERVICE CORP INTERNATIONAL | 21.37 | 11.29B | ||
| ADT | ADT INC | 9.48 | 6.76B | ||
| HRB | H&R BLOCK INC | 8.9 | 5.31B | ||
| FTDR | FRONTDOOR INC | 14.69 | 4.37B | ||
| DRVN | DRIVEN BRANDS HOLDINGS INC | 12.32 | 2.57B | ||
| MATW | MATTHEWS INTL CORP-CLASS A | 22.08 | 856.86M | ||
| CSV | CARRIAGE SERVICES INC | 14.15 | 684.18M | ||
| WW | WW INTERNATIONAL INC-NEW | 31.73 | 259.94M | ||
| EWCZ | EUROPEAN WAX CENTER INC-A | 4.41 | 217.98M | ||
| BODI | BEACHBODY CO INC/THE | N/A | 72.25M | ||
| RGS | REGIS CORP | 0.71 | 61.50M | ||
| XWEL | XWELL INC | N/A | 2.52M |
Allurion Technologies, Inc. develops treatments for obesity. The company is headquartered in Natick, Massachusetts and currently employs 134 full-time employees. The company went IPO on 2021-03-29. The firm offers Allurion Virtual Care Suite, including the Allurion Mobile App for consumers and Allurion Insights for healthcare providers featuring the Iris AI Platform, and the Allurion Connected Scale. The Allurion Balloon is swallowed as a capsule under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia. The Allurion Balloon is a procedure-less intragastric balloon that does not require any surgery, endoscopy, or anesthesia for placement. The balloon is swallowed in a capsule during a discrete outpatient office visit that takes approximately 15 minutes (though times may vary across different outpatient offices). The Allurion Virtual Care Suite is a cutting-edge digital therapeutic that combines AI-powered remote patient monitoring tools with a behavior change program.
ALLURION TECHNOLOGIES INC
11 Huron Dr Ste 200
Natick MASSACHUSETTS US
Employees: 134
Phone: 15086474000
Allurion Technologies, Inc. develops treatments for obesity. The company is headquartered in Natick, Massachusetts and currently employs 134 full-time employees. The company went IPO on 2021-03-29. The firm offers Allurion Virtual Care Suite, including the Allurion Mobile App for consumers and Allurion Insights for healthcare providers featuring the Iris AI Platform, and the Allurion Connected Scale. The Allurion Balloon is swallowed as a capsule under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia. The Allurion Balloon is a procedure-less intragastric balloon that does not require any surgery, endoscopy, or anesthesia for placement. The balloon is swallowed in a capsule during a discrete outpatient office visit that takes approximately 15 minutes (though times may vary across different outpatient offices). The Allurion Virtual Care Suite is a cutting-edge digital therapeutic that combines AI-powered remote patient monitoring tools with a behavior change program.
The current stock price of ALUR is 1.755 USD. The price increased by 2.03% in the last trading session.
ALUR does not pay a dividend.
ALUR has a ChartMill Technical rating of 3 out of 10 and a ChartMill Fundamental rating of 0 out of 10.
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on ALUR.
You can find the ownership structure of ALLURION TECHNOLOGIES INC (ALUR) on the Ownership tab.